| scholarly article | Q13442814 |
| P50 | author | Alain Fischer | Q2636403 |
| Marina Cavazzana | Q15972056 | ||
| Salima Hacein-Bey-Abina | Q36332714 | ||
| Frederic D. Bushman | Q37377271 | ||
| Alexandrine Garrigue | Q41590861 | ||
| Angela Ciuffi | Q42431175 | ||
| Jeremy Leipzig | Q42888112 | ||
| Chantal Lagresle-Peyrou | Q45929227 | ||
| Fatine Benjelloun | Q125215193 | ||
| P2093 | author name string | Charles Berry | |
| Keshet Ronen | |||
| Gary P Wang | |||
| Chantal Lagresle-Peyrou | |||
| P2860 | cites work | Genome sequencing in microfabricated high-density picolitre reactors | Q24544260 |
| A census of human cancer genes | Q24647081 | ||
| Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences | Q24798872 | ||
| A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo | Q25255818 | ||
| The consensus coding sequences of human breast and colorectal cancers | Q27861035 | ||
| Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease | Q28143064 | ||
| LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 | Q28210584 | ||
| Hot spots of retroviral integration in human CD34+ hematopoietic cells | Q28302694 | ||
| Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice | Q28592390 | ||
| Selection of target sites for mobile DNA integration in the human genome | Q28766367 | ||
| Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome | Q28769415 | ||
| Transcription start regions in the human genome are favored targets for MLV integration | Q29618456 | ||
| HIV-1 integration in the human genome favors active genes and local hotspots | Q29618457 | ||
| The use of coded PCR primers enables high-throughput sequencing of multiple homolog amplification products by 454 parallel sequencing | Q30829701 | ||
| Retroviral DNA integration: viral and cellular determinants of target-site selection | Q33247467 | ||
| Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. | Q33945446 | ||
| Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. | Q34508425 | ||
| RTCGD: retroviral tagged cancer gene database | Q34923778 | ||
| Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer | Q35133845 | ||
| HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications | Q35914779 | ||
| Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy | Q35916190 | ||
| DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations | Q35916998 | ||
| Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy | Q38458501 | ||
| Atlas of genetics and cytogenetics in oncology and haematology, an interactive database | Q39541873 | ||
| Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. | Q40344301 | ||
| A role for LEDGF/p75 in targeting HIV DNA integration | Q40346940 | ||
| Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells | Q40492460 | ||
| RAG mutations in human B cell-negative SCID. | Q41159572 | ||
| Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. | Q42755157 | ||
| Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning | Q44044895 | ||
| Polyclonal long-term repopulating stem cell clones in a primate model | Q45855127 | ||
| A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency | Q45857796 | ||
| Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples | Q45876897 | ||
| Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity | Q45887057 | ||
| HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. | Q53625219 | ||
| Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome | Q55670920 | ||
| In vivo expansion of the endogenous B-cell compartment stimulated by radiation and serial bone marrow transplantation induces B-cell leukaemia in mice | Q57130697 | ||
| Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors | Q73800420 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pyrosequencing | Q2342248 |
| P304 | page(s) | e49 | |
| P577 | publication date | 2008-04-14 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer | |
| P478 | volume | 36 |
| Q35041012 | A method to sequence and quantify DNA integration for monitoring outcome in gene therapy |
| Q24630047 | A transposon and transposase system for human application |
| Q35972798 | Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites |
| Q34956211 | Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells |
| Q92864734 | At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids |
| Q37014688 | Bacteriophage Mu integration in yeast and mammalian genomes |
| Q34025078 | Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells |
| Q46018826 | CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia. |
| Q34962407 | Cancer gene discovery in mouse and man. |
| Q33713961 | Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis |
| Q35808693 | Characterization of Equine Infectious Anemia Virus Integration in the Horse Genome |
| Q50093570 | Clonal analysis of lineage fate in native haematopoiesis |
| Q35652683 | Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions |
| Q33641937 | Comparing DNA integration site clusters with scan statistics. |
| Q45855528 | Comprehensive genomic access to vector integration in clinical gene therapy |
| Q35029930 | Correction of murine β-thalassemia after minimal lentiviral gene transfer and homeostatic in vivo erythroid expansion |
| Q44841000 | Counting stem cells: methodological constraints. |
| Q35202343 | Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells |
| Q33760990 | Deciphering the code for retroviral integration target site selection |
| Q51846191 | Development and Evaluation of Quality Metrics for Bioinformatics Analysis of Viral Insertion Site Data Generated Using High Throughput Sequencing. |
| Q35086103 | Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemia |
| Q36947161 | Does retroviral insertional mutagenesis play a role in the generation of induced pluripotent stem cells? |
| Q39505924 | Dotting the I's and crossing the T's: integration analyses in transduced patient T cells |
| Q33896692 | Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial |
| Q39399864 | Engineering CAR-T cells |
| Q34124838 | Estimating abundances of retroviral insertion sites from DNA fragment length data. |
| Q37066318 | Evaluating a ligation-mediated PCR and pyrosequencing method for the detection of clonal contribution in polyclonal retrovirally transduced samples |
| Q37858878 | Ex vivo gene transfer and correction for cell-based therapies |
| Q39917097 | Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions |
| Q38364511 | Gene therapy for primary immunodeficiencies. |
| Q33565251 | Genome walking by next generation sequencing approaches |
| Q37919127 | Genome walking in eukaryotes. |
| Q45862487 | Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing |
| Q37849774 | Genotoxicity of retroviral hematopoietic stem cell gene therapy |
| Q38919402 | HIV integration site distributions in resting and activated CD4+ T cells infected in culture |
| Q33851502 | HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2 |
| Q36352523 | HTLV-1-infected T cells contain a single integrated provirus in natural infection |
| Q33877425 | Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. |
| Q34296095 | High-Throughput, Sensitive Quantification of Repopulating Hematopoietic Stem Cell Clones |
| Q36323403 | INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes |
| Q38874946 | INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions. |
| Q54432736 | Identification of HIV integration sites in infected host genomic DNA. |
| Q28290118 | Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 |
| Q33713156 | Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors |
| Q37135161 | Integration target site selection by a resurrected human endogenous retrovirus |
| Q37684882 | Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity |
| Q34459397 | Lentivector integration sites in ependymal cells from a model of metachromatic leukodystrophy: non-B DNA as a new factor influencing integration |
| Q34385265 | Linear amplification mediated PCR--localization of genetic elements and characterization of unknown flanking DNA. |
| Q35125898 | Loss of p19Arf in a Rag1(-/-) B-cell precursor population initiates acute B-lymphoblastic leukemia |
| Q33924443 | Methods for integration site distribution analyses in animal cell genomes |
| Q37701291 | Multiplexing clonality: combining RGB marking and genetic barcoding. |
| Q35215395 | No evidence for clonal selection due to lentiviral integration sites in human induced pluripotent stem cells. |
| Q37089728 | Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome |
| Q33778662 | Quantification of HTLV-1 clonality and TCR diversity |
| Q45884677 | QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis |
| Q35260206 | Retroviral integration site selection. |
| Q37480480 | Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation |
| Q35261336 | Retroviral vectors: post entry events and genomic alterations |
| Q24628796 | Single-cell dissection of transcriptional heterogeneity in human colon tumors |
| Q36429491 | Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity |
| Q33712953 | Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance |
| Q38285749 | Strategies to antagonize miRNA functions in vitro and in vivo |
| Q59126661 | T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency |
| Q30053630 | The evolution of gene therapy in X-linked severe combined immunodeficiency |
| Q38997243 | Thymidine phosphorylase is both a therapeutic and a suicide gene in a murine model of mitochondrial neurogastrointestinal encephalomyopathy |
| Q24618997 | Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia |
| Q36710283 | Transgenic sheep generated by lentiviral vectors: safety and integration analysis of surrogates and their offspring |
| Q41869702 | VISPA: a computational pipeline for the identification and analysis of genomic vector integration sites |
| Q35913748 | Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations. |
Search more.